Price movement over the last 24 hours
ARK Next Generation Internet ETF vs Eli Lilly And Co — how do they compare? ARK Next Generation Internet ETF trades at $147, while Eli Lilly And Co trades at $1,189.05 (market cap $1.06T). The key difference: Eli Lilly And Co pays a 0.58% dividend while ARK Next Generation Internet ETF pays none. Which is the better fit depends on your goals.
| ARKW | LLY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $182.20 | $1.24K |
52-Week Low | $114.45 | $625.65 |
Market Cap | — | $1.06T |
Enterprise Value | — | $1.10T |
Dividend Yield | — | 0.58% |
Signals from Pluang's Aura AI — not financial advice
ARKW trades at $148.42, down 0.75% with a bullish technical signal from moving averages. The ETF shows neutral momentum oscillators with RSI at 52.51 suggesting balanced buying pressure. Support levels are established at $144 and $142, while resistance sits at $147 and $148. Recent news highlights Cathie Wood's continued focus on innovative technology investments through her ETF strategies.
The ETF's exposure to disruptive innovation themes presents growth potential amid technology sector momentum. Key risks include concentration in high-growth tech stocks and market volatility sensitivity. Institutional interest remains strong given ARK Invest's track record in identifying transformative technologies.
Eli Lilly (LLY) trades at $1,188.58, down 2.33% over 24 hours, but maintains a strong technical bullish trend with support near $1,172. The company demonstrates exceptional fundamental strength, with 2025 revenue surging to $65.18B and net income reaching $20.64B, driven by robust demand for its obesity and diabetes drugs. Recent news highlights a $400B market cap surge over the past year and positive analyst coverage, though valuation multiples remain elevated.
Outlook remains positive given Lilly's dominance in high-growth therapeutic areas and consistent earnings beats, but risks include intense competition from Novo Nordisk and rich valuations. Wall Street consensus is strongly bullish with a $1,340 price target, suggesting 13% upside from current levels, supported by institutional confidence in long-term growth prospects.
Trailing returns across standard periods
Latest headlines on both assets
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →